Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial
Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe website revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No other visible content changes were detected.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to study content or data were detected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedOnly a page revision label was updated: v3.4.1 was added and v3.4.0 removed; there are no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded glossary toggle options (Show glossary, Hide glossary) and new QC/versioning metadata fields (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.3%

- Check78 days agoChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.